-
Something wrong with this record ?
Pre-clinical evidence that methylphenidate increases motivation and/or reward preference to search for high value rewards
LN. Pulido, JA. Pochapski, A. Sugi, JY. Esaki, JL. Stresser, WN. Sanchez, G. Baltazar, D. Levcik, R. Fuentes, C. Da Cunha
Language English Country Netherlands
Document type Journal Article
- MeSH
- Attention Deficit Disorder with Hyperactivity * drug therapy MeSH
- Rats MeSH
- Methylphenidate * pharmacology therapeutic use MeSH
- Motivation MeSH
- Reward MeSH
- Rats, Wistar MeSH
- Central Nervous System Stimulants * pharmacology therapeutic use MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Methylphenidate is a stimulant used to treat attention deficit and hyperactivity disorder (ADHD). In the last decade, illicit use of methylphenidate has increased among healthy young adults, who consume the drug under the assumption that it will improve cognitive performance. However, the studies that aimed to assess the methylphenidate effects on memory are not consistent. Here, we tested whether the effect of methylphenidate on a spatial memory task can be explained as a motivational and/or a reward effect. We tested the effects of acute and chronic i.p. administration of 0.3, 1 or 3 mg/kg of methylphenidate on motivation, learning and memory by using the 8-arm radial maze task. Adult male Wistar rats learned that 3 of the 8 arms of the maze were consistently baited with 1, 3, or 6 sucrose pellets, and the number of entries and reentries into reinforced and non-reinforced arms of the maze were scored. Neither acute nor chronic (20 days) methylphenidate treatment affected the number of entries in the non-baited arms. However, chronic, but not acute, 1-3 mg/kg methylphenidate increased the number of reentries in the higher reward arms, which suggests a motivational/rewarding effect rather than a working memory deficit. In agreement with this hypothesis, the methylphenidate treatment also decreased the approach latency to the higher reward arms, increased the approach latency to the low reward arm, and increased the time spent in the high, but not low, reward arm. These findings suggest that methylphenidate may act more as a motivational enhancer rather than a cognitive enhancer in healthy people.
Departamento de Neurociencias Facultad de Medicina Universidad de Chile Santiago de Chile Chile
Department of Biochemistry Universidade Federal do Parana Curitiba Brazil
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031958
- 003
- CZ-PrNML
- 005
- 20230131151447.0
- 007
- ta
- 008
- 230120s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbr.2022.114065 $2 doi
- 035 __
- $a (PubMed)36037842
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pulido, Laura N $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil
- 245 10
- $a Pre-clinical evidence that methylphenidate increases motivation and/or reward preference to search for high value rewards / $c LN. Pulido, JA. Pochapski, A. Sugi, JY. Esaki, JL. Stresser, WN. Sanchez, G. Baltazar, D. Levcik, R. Fuentes, C. Da Cunha
- 520 9_
- $a Methylphenidate is a stimulant used to treat attention deficit and hyperactivity disorder (ADHD). In the last decade, illicit use of methylphenidate has increased among healthy young adults, who consume the drug under the assumption that it will improve cognitive performance. However, the studies that aimed to assess the methylphenidate effects on memory are not consistent. Here, we tested whether the effect of methylphenidate on a spatial memory task can be explained as a motivational and/or a reward effect. We tested the effects of acute and chronic i.p. administration of 0.3, 1 or 3 mg/kg of methylphenidate on motivation, learning and memory by using the 8-arm radial maze task. Adult male Wistar rats learned that 3 of the 8 arms of the maze were consistently baited with 1, 3, or 6 sucrose pellets, and the number of entries and reentries into reinforced and non-reinforced arms of the maze were scored. Neither acute nor chronic (20 days) methylphenidate treatment affected the number of entries in the non-baited arms. However, chronic, but not acute, 1-3 mg/kg methylphenidate increased the number of reentries in the higher reward arms, which suggests a motivational/rewarding effect rather than a working memory deficit. In agreement with this hypothesis, the methylphenidate treatment also decreased the approach latency to the higher reward arms, increased the approach latency to the low reward arm, and increased the time spent in the high, but not low, reward arm. These findings suggest that methylphenidate may act more as a motivational enhancer rather than a cognitive enhancer in healthy people.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a methylfenidát $x farmakologie $x terapeutické užití $7 D008774
- 650 _2
- $a motivace $7 D009042
- 650 _2
- $a potkani Wistar $7 D017208
- 650 12
- $a stimulanty centrálního nervového systému $x farmakologie $x terapeutické užití $7 D000697
- 650 _2
- $a odměna $7 D012201
- 650 12
- $a hyperkinetická porucha $x farmakoterapie $7 D001289
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pochapski, Jose A $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil; Department of Biochemistry, Universidade Federal do Parana, Curitiba, Brazil
- 700 1_
- $a Sugi, Adam $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil; Department of Biochemistry, Universidade Federal do Parana, Curitiba, Brazil
- 700 1_
- $a Esaki, Julie Y $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil
- 700 1_
- $a Stresser, Joao L $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil
- 700 1_
- $a Sanchez, William N $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil; Department of Biochemistry, Universidade Federal do Parana, Curitiba, Brazil; Integrative Neurobiology Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA
- 700 1_
- $a Baltazar, Gabriel $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil; Department of Biochemistry, Universidade Federal do Parana, Curitiba, Brazil
- 700 1_
- $a Levcik, David $u Laboratory of Neurophysiology of Memory, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Fuentes, Romulo $u Departamento de Neurociencias, Facultad de Medicina, Universidad de Chile, Santiago de Chile, Chile
- 700 1_
- $a Da Cunha, Claudio $u Laboratorio de Fisiologia e Farmacologia do Sistema Nervoso Central, Department of Pharmacology, Universidade Federal do Parana, Curitiba, Brazil; Department of Biochemistry, Universidade Federal do Parana, Curitiba, Brazil. Electronic address: dacunha@ufpr.br
- 773 0_
- $w MED00000660 $t Behavioural brain research $x 1872-7549 $g Roč. 437, č. - (2023), s. 114065
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36037842 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151443 $b ABA008
- 999 __
- $a ok $b bmc $g 1891013 $s 1183293
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 437 $c - $d 114065 $e 20220828 $i 1872-7549 $m Behavioural brain research $n Behav Brain Res $x MED00000660
- LZP __
- $a Pubmed-20230120